v3.22.2.2
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
shares in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-In Capital
Additional Paid-In Capital
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Income/(Loss)
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Equity, beginning balance (in shares) at Dec. 31, 2020     135,030          
Equity, beginning balance at Dec. 31, 2020 $ 151,047,000 $ (52,564,000) $ 135,000 $ 625,483,000 $ (65,535,000) $ 22,000 $ (474,593,000) $ 12,971,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Share-based compensation expense 15,694,000     15,694,000        
Issuance of common stock for the induced conversion related to convertible notes 13,104,000   $ 9,000 13,095,000        
Issuance of common stock for the induced conversion related to convertible notes (in shares)     9,083          
Issuance of common stock pursuant to exercise of stock options and vesting of restricted stock units, net (in shares)     1,229          
Issuance of common stock pursuant to exercise of stock options and vesting of restricted stock units, net and shares issued under the ESPP plan 8,226,000   $ 1,000 8,225,000        
Repurchase of common stock (shares)     (4,376)          
Repurchase of common stock (189,737,000)   $ (4,000) (189,733,000)        
Other comprehensive income (loss) (36,000)         (36,000)    
Net income 335,940,000           335,940,000  
Equity, ending balance (in shares) at Sep. 30, 2021     140,966          
Equity, ending balance at Sep. 30, 2021 281,674,000   $ 141,000 407,229,000   (14,000) (125,682,000)  
Equity, beginning balance (in shares) at Jun. 30, 2021     142,181          
Equity, beginning balance at Jun. 30, 2021 119,746,000   $ 142,000 461,897,000   (24,000) (342,269,000)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Share-based compensation expense 5,399,000     5,399,000        
Issuance of common stock pursuant to exercise of stock options and vesting of restricted stock units, net (in shares)     348          
Issuance of common stock pursuant to exercise of stock options and vesting of restricted stock units, net and shares issued under the ESPP plan 4,648,000   $ 0 4,648,000        
Repurchase of common stock (shares)     (1,563)          
Repurchase of common stock (64,716,000)   $ (1,000) (64,715,000)        
Other comprehensive income (loss) 10,000         10,000    
Net income 216,587,000           216,587,000  
Equity, ending balance (in shares) at Sep. 30, 2021     140,966          
Equity, ending balance at Sep. 30, 2021 281,674,000   $ 141,000 407,229,000   (14,000) (125,682,000)  
Equity, beginning balance (in shares) at Dec. 31, 2021     137,498          
Equity, beginning balance at Dec. 31, 2021 196,953,000   $ 138,000 256,347,000   (620,000) (58,912,000)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Share-based compensation expense 17,174,000     17,174,000        
Issuance of common stock for the induced conversion related to convertible notes 1,693,000   $ 1,000 1,692,000        
Issuance of common stock for the induced conversion related to convertible notes (in shares)     1,512          
Issuance of common stock pursuant to exercise of stock options and vesting of restricted stock units, net (in shares)     753          
Issuance of common stock pursuant to exercise of stock options and vesting of restricted stock units, net and shares issued under the ESPP plan 7,081,000   $ 1,000 7,080,000        
Capped call transaction (69,120,000)     (69,120,000)        
Repurchase of common stock (shares)     (4,552)          
Repurchase of common stock (200,001,000)   $ (5,000) (199,996,000)        
Other comprehensive income (loss) (1,216,000)         (1,216,000)    
Net income 144,427,000           144,427,000  
Equity, ending balance (in shares) at Sep. 30, 2022     135,211          
Equity, ending balance at Sep. 30, 2022 96,991,000   $ 135,000 13,177,000   (1,836,000) 85,515,000  
Equity, beginning balance (in shares) at Jun. 30, 2022     137,681          
Equity, beginning balance at Jun. 30, 2022 293,171,000   $ 138,000 271,169,000   (2,017,000) 23,881,000  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Share-based compensation expense 6,797,000     6,797,000        
Issuance of common stock for the induced conversion related to convertible notes 1,693,000   $ 1,000 1,692,000        
Issuance of common stock for the induced conversion related to convertible notes (in shares)     1,512          
Issuance of common stock pursuant to exercise of stock options and vesting of restricted stock units, net (in shares)     137          
Issuance of common stock pursuant to exercise of stock options and vesting of restricted stock units, net and shares issued under the ESPP plan 2,636,000   $ 1,000 2,635,000        
Capped call transaction (69,120,000)     (69,120,000)        
Repurchase of common stock (shares)     (4,119)          
Repurchase of common stock (200,001,000)   $ (5,000) (199,996,000)        
Other comprehensive income (loss) 181,000         181,000    
Net income 61,634,000           61,634,000  
Equity, ending balance (in shares) at Sep. 30, 2022     135,211          
Equity, ending balance at Sep. 30, 2022 $ 96,991,000   $ 135,000 $ 13,177,000   $ (1,836,000) $ 85,515,000